Advertisement:

Alternative content





Friday 18th of May 2012 - 05:11 PM
« Prev. Next »



Search Help
Published
Archive

Tip newspaper

Letter to the editor

Send image

Gothenburg researchers discover new tick-borne infectious disease


Linda Genborg 2011-10-26

Researchers at the Sahlgrenska Academy in Gothenburg have discovered a new tick-borne infectious disease. Only eight cases have been found around the world so far - three of them in the Gothenburg area.

The infection can cause blood clots in the legs and lungs of people with weak immune systems. The infection is successfully treated with antibiotics, but the blood clots can be fatal.

The researchers do not yet know how common the infection is.

- We were the first to discover this infection in a patient in 2009, says chief physician and professor of microbiology Christine Wennerås to SR.

It is not known how the infection affects healthy people. The researchers believe the symptoms are much milder, but they do not know for sure at this stage. It is believed every tenth tick carries the infection.

Post comment     Tip a friend     Print







In collaboration with AstraZeneca

US patent approval for Promimic



The Gothenburg-based medical device company Promimic has obtained US patent approval for its thin implant coating HAnano...

More

Billion dollar acquisition for AstraZeneca


AstraZeneca is acquiring American bio technology company Ardea Biosciences for 1 billion US dollars, around 6.7 billion...

More

Meet Wayne - the expat who stayed

Wayne Brailsford

"I sort of got asked ‘Would you be interested to go and work in our sister site in Sweden for two years? ´ I sort of thought, why not." More

New Strokefinder ready for clinical study


The first generation of Medfield Diagnostics' supervisory Strokefinder is now ready to be part of a clinical study of... More

"Mölndal facility stands strong"


AstraZeneca's Mölndal facility stands strong. This is Karin Wingstrand's, VP and Head of Clinical Development, main... More

Broken heart: researchers look for answers


Can you die from a broken heart? Yes, it's possible, but most people survive. A team of heart researchers at the Sahlgrenska... More

New collaboration to increase clinical trials


Region Västra Götaland (VGR) wants more clinical trials to take place in the county. It has entered a... More

Meet Arvid - Gothenburg's Nobel prize winner



The discoveries of Arvid Carlsson have been crucial for our understanding of brain function. They have also ... More

AstraZeneca names Leif Johansson as new chairman


Former Volvo boss Leif Johansson is the proposed next chairman of AstraZeneca. The AstraZeneca board has proposed he takes... More

Pierre Guyot: embrace diversity



Pierre Guyot is the Parisian who moved to Gothenburg, and likes it. Now the CEO of Mölnlycke Health Care, Pierre has... More

First patients trial cancer vaccine


Gothenburg-based Immunicum has begun phase I/II clinical trials on the first patients for its cancer vaccine.

In total 12...
More

GU researchers give hope to infertile women

Professor Kui Liu

Researchers at the University of Gothenburg (GU) have made a discovery that could help women who have difficulties... More

Mölnlycke buys US Brennen Medical


Med-tech. Gothenburg-based Mölnlycke Health Care has acquired American burn and wound care business Brennen Medical. More

Encubator enters new collaboration with AstraZeneca


Business incubator Encubator AB has entered a new collaboration with pharmaceutical giant AstraZeneca. The project, which... More

Large study can save many hearts


On Valentine's Day, February 14, begins a large heart study at the Sahlgrenska University Hospital. 1,000 Gothenburgers... More

Cultivated corneas - new method in Gothenburg


Cultivated corneas may become reality. Researchers at the University of Gothenburg have been able to grow stem cells on... More

Stem cell researcher awarded grant from Brain Foundation


Gothenburg stem cell researcher Charlotta Lindwall has received a research grant for 280,000 kronor from the Swedish Brain... More

Life Science a prioritzed cluster in West Sweden


The Life Science sector in West Sweden has been identified as one of five prioritized clusters by leading representatives... More

10 million kronor to cardiac disease research in Gbg


Three cardiac disease researchers at the Sahlgrenska Academy and the Sahlgrenska Hosptial in Gothenburg have been granted... More

International award to Medfield Diagnostics


Gothenburg based life science company Medfield Diagnostics has won an international design award for their stroke helmet,... More

From India to Gothenburg via the UK

Bindhu, Aditi and Vidya

A new life in Gothenburg. It is November 2010 and Bindhu Gururajan and Vidya Sudheendara jump on a flight to Gothenburg...
More

Gothenburg researchers discover new tick-borne infectious disease


Researchers at the Sahlgrenska Academy in Gothenburg have discovered a new tick-borne infectious disease. Only eight cases... More

New drug can help insomnia sufferers


A new drug is offering hope to sufferers of insomnia. An extensive clinical trial, which included patients in Gothenburg,... More

Brilique listed as major research development


AstraZeneca's new heart-drug, Brilique (ticagrelor tablets) is one of this year's most important research developments,... More

AstraZeneca to build factory in China


Pharmaceutical company AstraZeneca will invest around 1.4 billion kronor (200 million dollar), in a new factory in China.... More

ESC recommends Brilique in new guidelines



AstraZeneca's new heart-drug, Brilique (ticagrelor), has been recommended for treatment of acute coronary syndrome (ACS) by... More

AstraZeneca breast cancer drug receives approval in Japan


AstraZeneca's Faslodex 500mg has received regulatory approval in Japan, for the treatment of postmenopausal women with... More

Park Annual 2011: innovation, sustainability and democracy


Park Annual is one of the largest life science events in the Gothenburg calendar. The seventh edition of the event took...
More

French biotech company to buy Cellartis


Gothenburg stem cell company Cellartis announced on Thursday that it is to be acquired by French biotech company Cellectis. More

New heart drug from AstraZeneca


AstraZeneca announced on Tuesday that its heart drug Axanum has received positive agreement for approval in 23 EU countries,... More

4.9 million kronor to local life science companies


Four Gothenburg-based companies active in life science have received almost 5 million kronor in funding from the VINNOVA... More

Opportunities and challenges for the life science sector: new report


Gothenburg and Västra Götaland needs to strengthen its brand to become more attractive to those seeking employment... More

At least 100 new jobs to AstraZeneca

Astra Zeneca R&D Mölndal

230 people will move from AstraZeneca in Lund to Mölndal. But there are still about 100 positions that need to be... More

Life Science: "Advantages of West Sweden should be better known"


Ingvar Carlsson, the former Social Democratic Prime Minister of Sweden, was recently appointed by Region Västra Gö... More

Former PM to coordinate Life Science sector


Former Prime Minister of Sweden, Ingvar Carlsson, will be in charge of a new Life Science coordination project in Vä... More


Main partners:


Social media:










Gothenburg photos:





Advertisements:

Alternative content






Most read